Safety and Efficacy of Abatacept Versus Placebo in Participants With Psoriatic Arthritis

NCT00534313 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

191

Enrollment

INDUSTRY

Sponsor class

Stopped Lack of efficacy with respect to skin-related lesions in the short-term phase

Conditions

Psoriatic Arthritis

Interventions

DRUG: Abatacept
DRUG: Placebo

Sponsor

Bristol-Myers Squibb